Topical Interleukin 1 Receptor Antagonist for Treatment of Dry Eye Disease: A Randomized Clinical Trial

IMPORTANCE: The immunopathogenic mechanisms of dry eye disease (DED), one of the most common ophthalmic conditions, is incompletely understood. Data from this prospective, double-masked, randomized trial demonstrate that targeting interleukin 1 (IL-1) by topical application of an IL-1 antagonist is...

Full description

Saved in:
Bibliographic Details
Main Authors: Amparo, Francisco, Dastjerdi, Mohammad H., Okanobo, Andre, Ferrari, Giulio, Smaga, Leila, Hamrah, Pedram, Jurkunas, Ula, Schaumberg, Debra A., Dana, Reza
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4167802/
https://ncbi.nlm.nih.gov/pubmed/23599118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2013.195
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items